A carregar...
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4(+) T cells partly via transforming growth factor‐β1
Tolerogenic dendritic cells (tolDC) are a new immunotherapeutic tool for the treatment of rheumatoid arthritis (RA) and other autoimmune disorders. We have established a method to generate stable tolDC by pharmacological modulation of human monocyte‐derived DC. These tolDC exert potent pro‐tolerogen...
Na minha lista:
Publicado no: | Clin Exp Immunol |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5167049/ https://ncbi.nlm.nih.gov/pubmed/27667787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12870 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|